Even though 2 (28.6%) serous borderline tumors, 1 (50.0%) endometrioid borderline tumor, and 1 (50.0%) seromucinous borderline tumor exhibited moderate-to-strong p16 staining intensity in the tumor cells, none of the cases showed diffuse expression. This evidence concerns the gene CDKN2A and neoplasm.